Global research to combat the COVID-19 pandemic has led to the isolation and
characterization of thousands of human antibodies to the SARS-CoV-2 spike protein …

To fully decipher the immunogenicity of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a …

Comprehensive profiling of humoral antibody response to severe acute respiratory
syndrome (SARS) coronavirus-2 (CoV-2) proteins is essential in understanding the host …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel beta-coronavirus
that has emerged and caused a global pandemic of coronavirus disease 2019 (COVID-19) …

Background: Control of the COVID-19 pandemic will rely on SARS-CoV-2 vaccine-elicited
antibodies to protect against emerging and future variants; an understanding of the unique …

SARS-CoV-2 is a novel betacoronavirus that caused coronavirus disease 2019 and has
resulted in millions of deaths worldwide. Novel coronavirus infections in humans have …

SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic,
infecting millions of people and causing hundreds of thousands of deaths. The Spike …

Antibodies are a principal determinant of immunity for most RNA viruses and have promise
to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 …

COVID-19 is caused by SARS-CoV-2. 1, 2 By July 25, 2020, globally, 15,672,841 diagnosed
cases and 638,352 deaths were reported (https://coronavirus. jhu. edu/map. html). 3 High …

A comprehensive analysis of the humoral immune response to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is essential in understanding COVID-19 …